Papers
2
Total Citations
62
H-Index
2
About
Chandan Guha is a leading researcher in radiation oncology, whose work bridges the critical gap between pre-clinical innovation and clinical application. His primary research focuses on the therapeutic optimization of head and neck cancers, particularly through the use of advanced surgical and radiation technologies. Guha’s most impactful contribution is his investigation into Transoral Robotic Surgery (TORS) for Oropharyngeal Squamous Cell Carcinoma. His landmark 2018 study (50 citations) provided crucial evidence on how TORS can improve survival outcomes and reduce the need for adjuvant chemotherapy, directly influencing modern treatment paradigms for this disease. Beyond the clinic, Guha is a pioneer in translational radiobiology. He developed a novel, efficient monthly quality management program for robotic image-guided small animal radiation systems (2015, 12 citations). This work is foundational for ensuring the precision and dosimetric accuracy required in pre-clinical radiotherapy, enabling more reliable translation of lab findings into effective human therapies. Through these efforts, Guha has established himself as a key figure in refining both the tools and the strategies that define the future of radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2